covid drug

The drug consists of Nirmatrelvir tablets, which are co-packaged and co-administered with Ritonavir tablets. Strides Pharma Science on Monday announced a sub-licensing agreement with the Medicines Patent Pool (MPP) to commercialise a…

Icatibant was sold by Japan’s Takeda Pharmaceutical Co as Firazyr that blocks a protein called bradykinin receptor b2 in the kinin system. According to a small study, patients that are infected with the Omicron virus of SARS-CoV-2 remain…

China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the country. The National…

The country’s task force on Covid-19 is still deliberating whether to include Molnupiravir in the national protocol for treatment of coronavirus as the oral anti-viral drug has major safety concerns, the Indian Council of Medical Research…

By Express News Service BENGALURU: The experimental COVID-19 drug Molnupiravir could be promising in treating Covid patients with mild to moderate symptoms, going by the announcement made on October 2 by the company,…

By contrast, pulmonary delivery is a non-invasive administration route that can maximise local concentration in the lung and reduce systemic exposure, thereby reducing the risk of adverse effects and improving therapeutic efficacy.…

By PTI WASHINGTON: Scientists have identified a novel target for a drug that can treat the SARS-CoV-2 virus, which causes COVID-19, and also help tackle a future coronavirus pandemic. The researchers at Northwestern…

There are 28 post-covid long-term complications that the WHO has identified. (Representational Image)A Covid-19 drug manufactured by Kerala-based company, PNB Vesper, has received nod by DCGI to conduct Phase 3 clinical trials. The company…

"Given the current pandemic, while awaiting collective immunity through vaccination around the world, the need for treatments to prevent Covid-19 complications among patients who contract the disease remains," said Jean-Claude Tardif,…

It can also be administered to those suffering from an immuno-compromising condition or those with weakened immunity on account of immune suppressive treatment. ‘The 'antibody cocktail therapy' is for those above the age of 65, who are…